Centrus Energy Corp. (LEU) financials
NYSE · Energy · Uranium · 467 employees · CEO Amir V. Vexler
- Price
- $103.29 -6.57%
- Market cap
- $2.04B
- Enterprise value
- $1.35B
- Last report
- Q2 '26 filed 2026-08-06
- Next report
- 2026-11-04
Revenue (TTM)$474M+8.5% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)1.6%-19.4 pp vs a year agoOperating income $7.4M
Net income (TTM)$48.5M-53.7% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)-$164M-253.7% vs a year agoCapex $109M
Diluted EPS (TTM)$2.20-63.9% vs a year agoSum of the last 4 quarters
Net cash$691M+71.4% vs a year agoCash + short-term investments - debt
Valuation & key figures
- Market cap
- $2.04B EV $1.35B
- Revenue
- $474M Trailing 12 months
- Revenue growth
- +7% FY2026 consensus
- Profit margin
- 10.2% Net income / revenue, TTM
- P/E
- 41.2× Forward 42.6× (FY2026)
- P/S
- 4.3× Price / sales, TTM
- EV / EBITDA
- 18.5× TTM
- Free cash flow
- -$164M Trailing 12 months
- Net income
- $48.5M Trailing 12 months
- Revenue estimate
- $480M FY2026 consensus
- Earnings
- 2026-11-04
- Dividend
- – No dividend
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-08-05): revenue beat by 17.5%, EPS beat by 5.2%Revenue $176M vs $150M expected (+17.5%); EPS $0.77 vs $0.73 (+5.2%).
- Revenue growth accelerating: 14.0% year on yearQ2 '26 revenue $176M, against an average of 3.2% over the four quarters before.
- Operating margin 1.6% (TTM), -19.4 pp on a year agoOperating income grew -91.9% while revenue grew 8.5%.
- 84.4% of pre-tax profit is non-operatingPre-tax income $47.4M vs operating income $7.4M (TTM). Gains on equity stakes and other one-off items lift net income and EPS - operating income is the cleaner measure of the business.
- Capex 23.0% of revenue (a year ago 1.7%)$109M invested in the last 4 quarters (+1,370.3% on a year earlier). Free cash flow -$164M = -337.7% of net income.
- Diluted share count up 20.8% in a year21.9M diluted shares in Q2 '26, 18.1M a year earlier.
- Net cash $691MCash + short-term investments $1.87B, debt incl. leases $1.18B; a year ago net cash $403M.
Last quarter: Q2 '26
Quarter ended 2026-06-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q2 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | $176M | $155M | +14.0% |
| Gross margin | 28.3% | 34.9% | -6.6 pp |
| Operating income | $10.4M | $33.5M | -69.0% |
| Operating margin | 5.9% | 21.7% | -15.8 pp |
| Net income | $16.8M | $28.9M | -41.9% |
| Diluted EPS | $0.77 | $1.59 | -51.6% |
| Operating cash flow | $18.4M | $52.8M | -65.2% |
| Capex | $71.6M | $3.6M | +1,888.9% |
| Free cash flow | -$53.2M | $49.2M | -208.1% |
| R&D | $0 | $3.3M | -100.0% |
| Stock-based compensation | $17.7M | $4.2M | +321.4% |
Reported vs consensus
2026-08-05| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $176M | $150M | +17.5% |
| EPS (as estimated) | $0.77 | $0.73 | +5.2% |
From the report of 2026-08-05 for Q2 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyRevenue by business line
stacked, quarterly| Segment | Q2 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| Product | $153M | +22.0% | 46.6% | $367M | -27.0% | |
| Separative Work Units | $100M | -20.4% | 30.3% | $263M | -34.2% | |
| Uranium | $53.4M | – | 16.2% | $104M | – | |
| Service | $22.7M | -21.2% | 6.9% | – | – |
Revenue by region
share of total| Segment | Q2 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| United States | $35.4M | -38.1% | 23.1% | $331M | – | |
| Non-US | $118M | – | 76.9% | – | – | |
| Other Foreign | – | – | – | – | – |
Margins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- -$55M
- Capex
- -$109M
- Buybacks
- $0
- Dividends
- $0
- Acquisitions
- $0
- Net debt issued
- $782M
- Stock-based compensation
- $19.2M
- Free cash flow
- -$164M
- Returned to shareholders / FCF
- 0.0%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 41.2× | 19.0× | 5.0× – 56.1× |
| EV / EBITDA | 18.5× | 12.5× | 4.2× – 33.0× |
| EV / Sales | 2.8× | 3.3× | 1.6× – 8.1× |
| Price / FCF | -12.4× | 64.1× | 13.8× – 139.4× |
| Price / Book | 2.4× | 12.7× 3 of 5 years | 5.7× – 25.6× |
| FCF yield | -8.0% | 3.2% | 0.7% – 7.2% |
| Return on invested capital | 0.4% | 15.3% | 2.2% – 36.7% |
| Return on equity | 7.1% | 24.6% | -123.3% – 261.3% |
Analysts
Consensus target $185.64 (+79.7%)
range $115.00 – $300.00 · rating Hold
Strong buy0
Buy7
Hold8
Sell0
Strong sell0
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $480M | +7.0% | $2.43 | -37.8% | 42.6× | 8 |
| FY2027 | $500M | +4.1% | $3.52 | +45.2% | 29.3× | 8 |
| FY2028 | $472M | -5.5% | $3.09 | -12.2% | 33.4× | 7 |
| FY2029 | $484M | +2.4% | $2.54 | -17.8% | 40.7× | 2 |
| FY2030 | $607M | +25.4% | $3.36 | +32.3% | 30.7× | 4 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Every reported line
All 229 figures Centrus Energy Corp. tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).
| Line (SEC label) | Latest quarter | Year ago | y/y | Latest FY | Prior FY | y/y |
|---|---|---|---|---|---|---|
| Accounts Payable and Accrued Liabilities, Current | $74M | $33.1M | +123.6% | $41.6M | $38.8M | +7.2% |
| Accounts Payable, Other, Current | $10M2025-12-31 | $5.8M | +72.4% | $10M | $5.8M | +72.4% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $25.6M | $31.3M | -18.2% | $30.7M | $80M | -61.6% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $7.5M | $5.9M | +27.1% | $6.7M | $5.3M | +26.4% |
| Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment | – | – | – | $1.4M | $1M | +40.0% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$800K | -$600K | -33.3% | -$700K | -$500K | -40.0% |
| Additional Paid in Capital | $816M | $378M | +115.8% | $762M | $237M | +222.3% |
| Amortization of Debt Discount (Premium) | – | – | – | $3.4M | $300K | +1,033.3% |
| Amortization of Debt Issuance Costs | $1.4M2025-12-31 | $300K | +366.7% | $3.4M | $300K | +1,033.3% |
| Amortization of Debt Issuance Costs and Discounts | $1.4M | $0 | – | – | – | – |
| Amortization of Intangible Assets | $2.5M | $3.7M | -32.4% | $8.4M | $9.8M | -14.3% |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 02025-09-30 | 34K | -100.0% | 02020-12-31 | 67K | -100.0% |
| Assets | $2.53B | $1.31B | +92.5% | $2.45B | $1.09B | +123.7% |
| Assets, Current | $2.32B | $1.25B | +85.3% | $2.36B | $1.02B | +132.8% |
| Billed Contracts Receivable | $16.1M | $21.4M | -24.8% | $19.9M | $69.8M | -71.5% |
| Cash and Cash Equivalents, at Carrying Value | $1.87B | $833M | +124.3% | $1.96B | $671M | +191.5% |
| Cash and Cash Equivalents, Fair Value Disclosure | $1.96B2025-12-31 | $671M | +191.5% | $1.96B | $671M | +191.5% |
| Cash Surrender Value, Fair Value Disclosure | $600K | $400K | +50.0% | $500K | $400K | +25.0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $1.9B | $847M | +124.5% | $1.96B | $704M | +178.4% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $700K | $161M | -99.6% | $1.26B | $470M | +167.1% |
| CashHeldInForeignCurrency | $100K | $200K | -50.0% | $100K | $500K | -80.0% |
| Common Stock, Shares, Issued | 19.7M2025-12-31 | 16.8M | +17.3% | 19.7M | 16.8M | +17.3% |
| Contract with Customer, Liability, Current | $85M | $155M | -45.1% | $131M | $216M | -39.4% |
| Conversion of Stock, Shares Converted | – | – | – | 0 | 0 | – |
| Convertible Notes Payable, Current | $1.5M2025-12-31 | $1.3M | +15.4% | $1.5M | $1.3M | +15.4% |
| Cost of Goods and Services Sold | $126M | $101M | +25.4% | $331M | $331M | +0.2% |
| Current Federal Tax Expense (Benefit) | – | – | – | $0 | $0 | – |
| Current Foreign Tax Expense (Benefit) | – | – | – | $0 | $0 | – |
| Current Income Tax Expense (Benefit) | – | – | – | $700K | $500K | +40.0% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $700K | $500K | +40.0% |
| Debt Instrument, Convertible, Conversion Price | $97.502025-09-30 | – | – | $97.502024-12-31 | – | – |
| Debt Instrument, Convertible, Conversion Ratio | 10.262025-09-30 | – | – | 10.262024-12-31 | – | – |
| Debt, Current | $0 | $0 | – | $0 | $6.1M | -100.0% |
| DebtInstrumentRepaidPrincipal | – | – | – | $74.3M | – | – |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | $8.1M | -$600K | +1,450.0% |
| Deferred Federal, State and Local, Tax Expense (Benefit) | – | – | – | -$700K | -$100K | -600.0% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | $0 | $0 | – |
| Deferred Income Tax Assets, Net | $15M | $13.9M | +7.9% | $21.9M | $29.3M | -25.3% |
| Deferred Income Tax Expense (Benefit) | – | – | – | $7.4M | -$700K | +1,157.1% |
| Deferred Revenue | $85M | $155M | -45.1% | $131M | $184M | -28.6% |
| Deferred Revenue, Revenue Recognized | $39.1M | $68.5M | -42.9% | $103M | $117M | -12.5% |
| Deferred Tax Assets, Gross | $381M2025-12-31 | $401M | -4.8% | $381M | $401M | -4.8% |
| Deferred Tax Assets, in Process Research and Development | $1.5M2025-12-31 | $2.4M | -37.5% | $1.5M | $2.4M | -37.5% |
| Deferred Tax Assets, Inventory | $19M2025-12-31 | $27.2M | -30.1% | $19M | $27.2M | -30.1% |
| Deferred Tax Assets, Net | $21.9M2025-12-31 | $29.3M | -25.3% | $21.9M | $29.3M | -25.3% |
| Deferred Tax Assets, Net of Valuation Allowance | $25.9M2025-12-31 | $34.9M | -25.8% | $25.9M | $34.9M | -25.8% |
| Deferred Tax Assets, Operating Loss Carryforwards | $159M2025-12-31 | $165M | -3.8% | $159M | $165M | -3.8% |
| Deferred Tax Assets, Property, Plant and Equipment | $178M2025-12-31 | $178M | -0.1% | $178M | $178M | -0.1% |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits | $21.1M2025-12-31 | $22.1M | -4.5% | $21.1M | $22.1M | -4.5% |
| Deferred Tax Assets, Tax Deferred Expense, Other | $700K2025-12-31 | $800K | -12.5% | $700K | $800K | -12.5% |
| Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | $500K2025-12-31 | $400K | +25.0% | $500K | $400K | +25.0% |
| Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other | $900K2025-12-31 | $3.8M | -76.3% | $900K | $3.8M | -76.3% |
| Deferred Tax Assets, Valuation Allowance | $355M2025-12-31 | $366M | -2.8% | $355M | $366M | -2.8% |
| Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs | $300K2025-12-31 | $400K | -25.0% | $300K | $400K | -25.0% |
| Deferred Tax Liabilities, Intangible Assets | $3.3M2025-12-31 | $4.9M | -32.7% | $3.3M | $4.9M | -32.7% |
| Deferred Tax Liabilities, Net | $4M2025-12-31 | $5.6M | -28.6% | $4M | $5.6M | -28.6% |
| Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) | -$2.9M2025-12-31 | $500K | -680.0% | -$2.9M | $17.3M | -116.8% |
| Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year | 9.0%2025-12-31 | 7.0% | +28.6% | 9.0% | 7.0% | +28.6% |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment | $02025-09-30 | $200K | -100.0% | – | – | – |
| Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage | 100.0%2025-12-31 | 100.0% | 0.0% | 100.0% | 100.0% | 0.0% |
Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-02